As of 2025-03-19, the EV/EBITDA ratio of XBiotech Inc (XBIT) is 2.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XBIT's latest enterprise value is -68.88 mil USD. XBIT's TTM EBITDA according to its financial statements is -34.47 mil USD. Dividing these 2 quantities gives us the above XBIT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-03-05 | 2.21 |
| 2025-03-04 | 2.23 |
| 2025-03-03 | 2.06 |
| 2025-02-28 | 1.91 |
| 2025-02-27 | 2.27 |
| 2025-02-26 | 2.37 |
| 2025-02-25 | 2.35 |
| 2025-02-24 | 2.32 |
| 2025-02-21 | 2.38 |
| 2025-02-20 | 2.26 |
| 2025-02-19 | 2.27 |
| 2025-02-18 | 2.34 |
| 2025-02-14 | 2.13 |
| 2025-02-13 | 2.18 |
| 2025-02-12 | 2.18 |
| 2025-02-11 | 2.10 |
| 2025-02-10 | 2.09 |
| 2025-02-07 | 2.28 |
| 2025-02-06 | 2.12 |
| 2025-02-05 | 2.00 |
| 2025-02-04 | 2.15 |
| 2025-02-03 | 2.08 |
| 2025-01-31 | 1.96 |
| 2025-01-30 | 1.82 |
| 2025-01-29 | 1.83 |
| 2025-01-28 | 1.95 |
| 2025-01-27 | 1.80 |
| 2025-01-24 | 1.79 |
| 2025-01-23 | 1.75 |
| 2025-01-22 | 1.69 |
| 2025-01-21 | 1.64 |
| 2025-01-17 | 1.64 |
| 2025-01-16 | 1.66 |
| 2025-01-15 | 1.58 |
| 2025-01-14 | 1.74 |
| 2025-01-13 | 1.62 |
| 2025-01-10 | 1.59 |
| 2025-01-08 | 1.48 |
| 2025-01-07 | 1.26 |
| 2025-01-06 | 1.06 |
| 2025-01-03 | 1.11 |
| 2025-01-02 | 1.33 |
| 2024-12-31 | 1.53 |
| 2024-12-30 | 1.41 |
| 2024-12-27 | 1.66 |
| 2024-12-26 | 1.28 |
| 2024-12-24 | 0.99 |
| 2024-12-23 | 1.04 |
| 2024-12-20 | -0.62 |
| 2024-12-19 | -0.58 |